Search Result

Results for "

6764

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Cytochrome P450 (2) MicroRNA (8) nAChR (1)
By Research Areas:	Cancer (8) Cardiovascular Disease (2) Neurological Disease (1)
Oligonucleotides:	miRNA mimics (2) miRNA agomirs (2) miRNA antagomirs (2) MicroRNAs (8) miRNA inhibitors (2)

Inhibitors & Agonists

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-120648A

CAY 10462 dihydrochloride	Cytochrome P450	Cardiovascular Disease
CAY 10434 dihydrochloride is a potent CYP4A hydroxylase inhibitor. CAY 10434 dihydrochloride improves contractile response to angiotensin II with the maximal contractile response (E_max) 6764 mg .

HY-R02087

*hsa-miR-6764-3p mimic*	MicroRNA	Cancer
hsa-miR-6764-3p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-6764-3p mimic hsa-miR-6764-3p mimic

HY-R02088

*hsa-miR-6764-5p mimic*	MicroRNA	Cancer
hsa-miR-6764-5p mimics are small, chemically synthesized double-stranded RNAs that mimic endogenous miRNAs and enable miRNA functional analysis by up-regulation of miRNA activity.

hsa-miR-6764-5p mimic hsa-miR-6764-5p mimic

HY-RI02087

*hsa-miR-6764-3p inhibitor*	MicroRNA	Cancer
hsa-miR-6764-3p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-6764-3p inhibitor hsa-miR-6764-3p inhibitor

HY-RI02088

*hsa-miR-6764-5p inhibitor*	MicroRNA	Cancer
hsa-miR-6764-5p inhibitors are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA inhibitors have full-length nucleotide 2'-methoxy modification. The miRNA inhibitors strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning.

hsa-miR-6764-5p inhibitor hsa-miR-6764-5p inhibitor

HY-R02087A

*hsa-miR-6764-3p agomir*	MicroRNA	Cancer
hsa-miR-6764-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-6764-3p agomir hsa-miR-6764-3p agomir

HY-R02088A

*hsa-miR-6764-5p agomir*	MicroRNA	Cancer
hsa-miR-6764-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-6764-5p agomir hsa-miR-6764-5p agomir

HY-RI02087A

*hsa-miR-6764-3p antagomir*	MicroRNA	Cancer
hsa-miR-6764-3p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-6764-3p antagomir hsa-miR-6764-3p antagomir

HY-RI02088A

*hsa-miR-6764-5p antagomir*	MicroRNA	Cancer
hsa-miR-6764-5p antagomirs are chemically-modified oligonucleotides that hybridize with mature miRNAs. The miRNA antagomirs have 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 1 cholesterol group at the 3' end, and full-length nucleotide 2'-methoxy modification. The miRNA antagomirs strongly compete with mature miRNAs to prevent the complementary pairing of miRNAs and their target genes, thereby inhibiting miRNAs from functioning. Stability of miRNA antagomirs appears to be significantly higher than miRNA inhibitors, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.

hsa-miR-6764-5p antagomir hsa-miR-6764-5p antagomir

HY-120648

CAY 10434	Cytochrome P450	Cardiovascular Disease
CAY 10434 is a potent CYP4A hydroxylase inhibitor. CAY 10434 improves contractile response to angiotensin II with the maximal contractile response (E_max) 6764 mg .

HY-114269

(-)-(S)-B-973B	nAChR	Neurological Disease
(-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity .

Cat. No.	Product Name		Classification